Ifeoluwa Jonathan Aderinto, FNP-C

Ifeoluwa Aderinto practices at Socal Breathe Free ASC LLC in Burbank, California.

Ifeoluwa Aderinto's NPI, 1578042214, was assigned on August 13, 2018. Ifeoluwa Aderinto holds California license 95009633.

Ifeoluwa Aderinto's primary practice is Socal Breathe Free ASC LLC, at 201 S Buena Vista St, Burbank, CA 91505 in Los Angeles County. The practice phone is (520) 979-6774.

Ifeoluwa Aderinto's primary practice is Socal Breathe Free ASC LLC in Burbank, California. Ifeoluwa Aderinto is also affiliated with Providence Saint Joseph Medical Center. The medical group on file is Comprehensive Spine & Pain Physicians. Dmand AI also links Ifeoluwa Aderinto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ifeoluwa Aderinto practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Ifeoluwa Aderinto's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Ifeoluwa Aderinto is licensed in California.

Dmand AI lists arthritis, fibromyalgia and chronic pain, joint arthropathy, joint pain, lower back pain, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain and neck pain and spine problems among the conditions Ifeoluwa Aderinto treats.

CMS data shows 1,629 Medicare services from Ifeoluwa Aderinto across 10 procedure codes in 2024, for 567 Medicare patients. Medicare paid $94,489 for them. Every service was in an office.

CMS counts 567 Medicare patients who saw Ifeoluwa Aderinto in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have arthritis, and 75% have high blood pressure. 69% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ifeoluwa Aderinto's median patient age at 72, with 62% women.

In 2024, Ifeoluwa Aderinto wrote 1,849 Medicare Part D claims for 366 patients. 98% of them were for generic drugs. CMS names the drug for 1,748 of them, across 24 drugs with 11 or more claims each, at $58,537 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 52 out of 100 for Ifeoluwa Aderinto for performance year 2024, reported as part of a group. Ifeoluwa Aderinto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ifeoluwa Aderinto as offering telehealth.

CMS Open Payments shows 12 general payments to Ifeoluwa Aderinto from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Saluda Medical Americas, Inc. paid the most, $97.